Technical Analysis for BIT - Biotron Limited  

Grade Last Price % Change Price Change
F 0.019 0.00% 0.000
BIT closed unchanged on Thursday, November 21, 2024, on 1.31 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 21
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Earnings Movers Other 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish 0.00%
Doji - Bearish? Reversal 0.00%
Doji - Bullish? Reversal 0.00%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Biotron Limited   Description

Biotron Limited is an Australia-based biotechnology company. The Company is engaged in the funding and management of intermediate, and applied biotechnology research and development projects. The Company is focused on the ongoing clinical development of its antiviral platform. The Company's lead antiviral drug, BIT225 is in mid-stage clinical development with approximately eight clinical trials completed. The Company has conducted clinical trails in human immunodeficiency virus-1 (HIV-1), hepatitis C virus (HCV) and HIV-1/HCV co-infected population. The clinical trials showed that BIT225 targets and reduces levels of HIV-1 residing in long-lived monocyte/macrophage reservoirs. BIT225 has clinical antiviral activity against both HIV-1 and HCV. BIT225 is pan-genotypic and is active against all HCV genotypes, including GT3. The Company designs and develops drugs that target a class of virus protein known as viroporins. Its earlier stage programs include Dengue, Influenza and others.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Media Biotechnology Drugs Flu Clinical Trial Protein Microbiology Hepatitis Siding Virus

Is BIT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.12
52 Week Low 0.016
Average Volume 654,013
200-Day Moving Average 0.045
50-Day Moving Average 0.020
20-Day Moving Average 0.020
10-Day Moving Average 0.019
Average True Range 0.001
RSI (14) 50.00
ADX 14.57
+DI 30.709
-DI 20.472
Chandelier Exit (Long, 3 ATRs) 0.021
Chandelier Exit (Short, 3 ATRs) 0.022
Upper Bollinger Bands 0.022
Lower Bollinger Band 0.018
Percent B (%b) 0.33
BandWidth 23.232
MACD Line -0.001
MACD Signal Line -0.001
MACD Histogram -0.0001
Fundamentals Value
Market Cap 13.34 Million
Num Shares 702 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio -6.33
Price-to-Sales 1098.99
Price-to-Book 8.36
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.019
Resistance 3 (R3) 0.019 0.019 0.019
Resistance 2 (R2) 0.019 0.019 0.019 0.019
Resistance 1 (R1) 0.019 0.019 0.019 0.019 0.019
Pivot Point 0.019 0.019 0.019 0.019 0.019
Support 1 (S1) 0.019 0.019 0.019 0.019 0.019
Support 2 (S2) 0.019 0.019 0.019 0.019
Support 3 (S3) 0.019 0.019 0.019
Support 4 (S4) 0.019